Although management of multiple myeloma has changed substantially in the last decade, it
is unknown whether the burden of ESRD due to multiple myeloma has changed, or whether
survival of patients with multiple myeloma on RRT has improved. Regarding ESRD due to
multiple myeloma necessitating RRT in the United States, we evaluated temporal trends
between 2001 and 2010 for demography-adjusted incidence ratios, relative to rates in 2001–
2002, and mortality hazards from RRT initiation, relative to hazards in 2001–2002. In this …